How will the recently-passed health reform legislation impact cardiologists and other physicians in the next year? What can physicians do to prepare for the changes ahead? Dr. Ralph Brindis, senior advisor for cardiovascular disease for Northern California Kaiser Permanente, clinical professor of medicine at the University of California, San Francisco, and president of the American College of Cardiology, joins host Dr. Jack Lewin to discuss various elements of health reform, including the further needs for tort reform as well as the sustainable growth rate formula (or SGR) and the need for payment reform. Dr. Brindis also weighs in on the role of registries in measuring success, ensuring quality of care, reducing disparities and decreasing healthcare costs.
Health Reform and Cardiology in the Year Ahead
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
How will the recently-passed health reform legislation impact cardiologists and other physicians in the next year? What can physicians do to prepare for the changes ahead? Dr. Ralph Brindis, senior advisor for cardiovascular disease for Northern California Kaiser Permanente, clinical professor of medicine at the University of California, San Francisco, and president of the American College of Cardiology, joins host Dr. Jack Lewin to discuss various elements of health reform, including the further needs for tort reform as well as the sustainable growth rate formula (or SGR) and the need for payment reform. Dr. Brindis also weighs in on the role of registries in measuring success, ensuring quality of care, reducing disparities and decreasing healthcare costs.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
FCS and SHTG: Are We Meeting the Need?
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
AI and Hair Loss: Measuring Progress with Data-Driven Insights
Challenges in AI-Driven Dermatology: Understanding Current Limitations
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Semaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?